Viravaxx AG
3Patents
3Active
3Granted
40Portfolio score
Filing activity: Nov 2, 2010 → Oct 30, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9638694B2 | Method for diagnosing a rhinovirus infection | Physics | 1 | Active |
| US11237166B2 | Method for detecting HIV-1-specific antibodies using clade C env polypeptides | Physics | 0 | Active |
| US10209257B2 | Solid support comprising HIV-1 clade C envelope peptides for the detection of HIV-1-specific antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.